Listening Beyond The Labels
Abstract
Alzheimers Disease (AD), a progressive neurodegenerative condition of cognitive decline, presents formidable challenges to patients, caregivers, and healthcare systems. Early identification is essential for successful intervention, but traditional diagnosis requires expensive neuroimaging and lengthy clinical assessments, which compromise access. This study proposes a semi-supervised machine learning strategy for AD diagnosis based on acoustic features from brief speech samples. The approach takes advantage of mel-spectrogram features to extract vocal patterns without manual transcription or linguistic preprocessing. Informative sound patterns are detected using a convolutional neural network (CNN) that gradually adds unlabeled speech data during training through pseudo-labeling. By emphasizing scalable, non-invasive methods that rely solely on unprocessed vocal inputs, this work presents a practical solution for large-scale cognitive screening in resource-limited settings.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Integrating Acoustic, Prosodic, and Phonological Features for Automatic Alzheimer's Detection
M Zakaria Kurdi·Frontiers in Aging NeurosciencePeer-reviewed·Apr 16, 2026
- Linguistic and Acoustic Biomarkers from Simulated Speech Reveal Early Cognitive Impairment Patterns in Alzheimers Disease
Akshita Debnath, Souhrid Sarkar·bioRxiv·Apr 8, 2026
- AI System Using Unsupervised Learning to Discover Novel Subtypes in Alzheimer's Disease
Poojak Patel, Raj Patel·bioRxiv·Feb 10, 2026
- Investigating Alzheimers Disease Biomarkers by Applying Machine Learning Models
Babak Khorsand, Shirin Salehi, … Nastaran Asri·bioRxiv·Mar 19, 2025
- Predicting Alzheimer's disease progression trajectory and clinical subtypes using machine learning
Vipul K. Satone, Rachneet Kaur, … Faraz Faghri·bioRxiv·Aug 26, 2020
- A novel technology for objective, accurate and non-invasive early diagnosis and monitoring of Alzheimer’s disease in clinics and clinical trials
Kaveh Vejdani, Thomas Liebmann, … Padideh Kamali‐Zare·bioRxiv·Oct 2, 2019